MB
Merge Bio Therapeutics Corp
SEC filingOther · Cambridge, MA
Amount raised$5Msold at filing
Total offering$15M$10M still open
Investors in the raise1count reported to the SEC
FiledSep 17, 2025first sale Aug 26, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Mark LipsteinPromoter
Steve LiapisDirector
Clinton HansenExecutive Officer, Promoter
Elias QuijanoDirector
Wesley WongExecutive Officer, Director, Promoter
Darren YangPromoter
Executive officers, directors and promoters as listed on the Form D.